MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development

• Benoît Stijlemans ,

  * E-mail: bstijlem@vub.ac.be

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Lin Leng,

  Affiliation Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Lea Brys,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Amanda Sparkes,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Liese Vansintjan,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Guy Caljon,

  Affiliation Unit of Veterinary Protozoology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Geert Raes,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Jan Van Den Abbeele,

  Affiliation Unit of Veterinary Protozoology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Jo A. Van Ginderachter,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Alain Beschin,

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯
• Richard Bucala ,

  Contributed equally to this work with: Richard Bucala, Patrick De Baetselier

  Affiliation Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Patrick De Baetselier

  Contributed equally to this work with: Richard Bucala, Patrick De Baetselier

  Affiliations Department of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, Myeloid Cell Immunology Laboratory, Vlaams Instituut voor Biotechnologie, Brussels, Belgium

  ⨯